Summary & Overview
HCPCS A2036: Cohealyx Collagen Dermal Matrix, per cm2
HCPCS Level II code A2036 denotes the Cohealyx collagen dermal matrix, billed per square centimeter as an add-on supply in addition to a primary surgical procedure. This code captures use of a biologic dermal scaffold applied during wound repair, soft-tissue reconstruction, or similar surgical interventions and is important for accurate supply reporting and reimbursement for adjunctive graft materials. Nationally, correct use of A2036 affects hospital and ambulatory surgery center supply documentation and can influence procedure cost reporting.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coding intent and clinical context for dermal matrix use, typical sites of service where the material is applied, and which payers are addressed in the analysis. The publication provides benchmarks and policy-relevant summaries where available, common billing modifiers used with add-on supply codes, and practical notes on documentation needed to support medical necessity. Clinical context covers typical applications in wound care and reconstructive surgery and how the add-on nature of A2036 interacts with primary procedure reporting.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and payer-specific coverage details.
Billing Code Overview
HCPCS Level II code A2036 describes the Cohealyx collagen dermal matrix and is reported per square centimeter as an add-on item that must be listed separately in addition to a primary procedure. The service type is dermal matrix grafting / wound reconstruction adjunct, used to provide a biologic scaffold for soft-tissue repair and dermal regeneration. The typical site of service is operating room, ambulatory surgical center, or other procedural setting where surgical wound repair or reconstruction is performed, depending on the primary procedure.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or deep partial-thickness cutaneous wound resulting from trauma, surgical excision of necrotic tissue, chronic non-healing ulceration, or oncologic resection requiring soft-tissue reconstruction and biologic scaffold support. The patient is evaluated in an outpatient wound care clinic or ambulatory surgical center. After debridement and wound bed preparation, the surgical team measures the defect in square centimeters and selects A2036 Cohealyx collagen dermal matrix as an additive graft material to augment dermal regeneration and support re-epithelialization. The product is billed per square centimeter as an add-on in addition to a primary procedure such as skin grafting or wound debridement. Typical clinicians involved include a plastic surgeon, general surgeon, podiatrist, or advanced wound care specialist. The workflow includes wound assessment, photographic documentation, measurement, informed consent, application of the dermal matrix to the prepared wound bed, fixation or dressing placement, and scheduled follow-up visits for graft take assessment and dressing changes. Billing is submitted with the primary procedure CPT code for the graft or debridement and the add-on HCPCS Level II code A2036 reported per square centimeter, using applicable modifiers to indicate payer-specific circumstances such as nudging for fee schedule status, reduced services, or bilateral/unilateral adjuncts.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|